✦ LIBER ✦
186 Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) – a case series
✍ Scribed by Fraser, I.M.; Brooke, A.M.; Dorey, N.E.; Toy, E.W.
- Book ID
- 121698014
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 61 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.